Endocyte, Inc. Announces Fourth Quarter and Full Year 2011 Earnings Conference Call

WEST LAFAYETTE, Ind., March 6, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company will host a conference call on Tuesday, March 13, at 4:30 p.m. EDT to discuss its fourth quarter and full year 2011 financial results and provide an operational update.